Top compounds associated with response to CAP2


Feature Type Standardized
Nominal ANOVA
mRNA TPCA-1 GDSC1000 pan-cancer AAC -0.13 0.0005
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.14 0.0006
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0006
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.24 0.0007
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.15 0.0007
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.16 0.0007
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC -0.14 0.0008
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.001
mRNA TW 37 GDSC1000 pan-cancer AAC 0.14 0.001
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.12 0.001
Download CSV